Author

Z. Kevin Lu

Observed name: Z Kevin Lu

Institution: University of South Carolina

Observed institution: University of South Carolina

OpenAlex ID: A5123879394

Lifetime cost-effectiveness of lecanemab for early Alzheimer’s disease

2026 · Xiangxiang Jiang, Gang Lv, et al. · Frontiers in Public Health · 2

Lead Exposure and the Coronary Heart Disease Epidemic

2026 · Jing Yuan, Xiangxiang Jiang, et al. · JAMA · 1

Editorial: Innovative value-based medicine: lessons from China's healthcare evolution

2026 · Gang Lv, Xiangxiang Jiang, et al. · Frontiers in Public Health · 1

Artificial intelligence–enabled causal estimate of Medicare drug plan integration in cancer care: A doubly robust machine learning instrumental variable analysis

2026 · Xiangxiang Jiang, Jayda Snipes, et al. · Journal of Managed Care & Specialty Pharmacy

Clinical benefit, price and epidemiology of orphan drugs approved in China: a cross-sectional analysis of orphan drug policy (ODP) in China

2026 · Jing Yuan, Minghui Li, et al. · BMJ Open

Hsd90 Health Care Utilization Differences Between Medicare Advantage and Standalone Part D Plans in Medicare Beneficiaries With Cancer

2026 · Z. Kevin Lu, Xiangxiang Jiang · Value in Health

Msr223 From Intention to Implementation: a Systematic Review of the Societal Perspective in Cost-effectiveness Analyses of Non-small Cell Lung Cancer Therapies

2026 · Xiaomo (Shawn) Xiong, Eszter Garami, et al. · Value in Health

Hpr82 Predicting Enrollment in Medicare Advantage Prescription Drug Plans and Standalone Prescription Drug Plans Among Medicare Cancer Beneficiaries: a Machine Learning Study

2026 · Xiangxiang Jiang, Z. Kevin Lu · Value in Health

Cost-effectiveness of traditional and novel neurotherapeutic agents for Alzheimer's disease: A systematic review

2026 · Xiangxiang Jiang, Gang Lv, et al. · Journal of Alzheimer s Disease

Works count: 9

Citation count: 4

H-index: 1

I10-index: